Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1/2 5Phase 1 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Breast Neoplasms 27Lymphoma 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Non-Hodgkin 21Leukemia 21Multiple Myeloma 18Leukemia, Myeloid, Acute 18Lymphoma, Large B-Cell, Diffuse 17Hodgkin Disease 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma, Follicular 15Leukemia, Lymphocytic, Chronic, B-Cell 14Congenital Abnormalities 12Lymphoma, B-Cell, Marginal Zone 11Burkitt Lymphoma 11Primary Myelofibrosis 10Myeloproliferative Disorders 10Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myeloid, Accelerated Phase 9Neoplasms, Plasma Cell 8Dendritic Cell Sarcoma, Interdigitating 8Blast Crisis 8Recurrence 7Sezary Syndrome 6Myelodysplastic-Myeloproliferative Diseases 6Mycosis Fungoides 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6

Interventions

fludarabine 1Immunotherapy, Adoptive 1Diet 1Cyclophosphamide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, B-Cell × Cyclophosphamide × Clear all
NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

First Affiliated Hospital of Wenzhou Medical University

Phase NA Unknown
18 enrolled
GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡